UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid

Journal of investigative dermatology, 2016-11, Vol.136 (11), p.2201-2210

2016

Volltextzugriff (PDF)

Nonbullous pemphigoid: A systematic review

Journal of the American Academy of Dermatology, 2018-05, Vol.78 (5), p.989-995.e2

2018

Volltextzugriff (PDF)

Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid

Journal of dermatology, 2018-05, Vol.45 (5), p.596-599

2018

Volltextzugriff (PDF)

Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome

Scientific reports, 2015-12, Vol.5 (1), p.18001-18001, Article 18001

2015

Volltextzugriff (PDF)

Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid

Acta dermato-venereologica, 2023-03, Vol.103, p.adv00888-adv00888

2023

Volltextzugriff (PDF)

A case of bullous pemphigoid complicated by mucosal lesions due to mucosal‐dominant pemphigus vulgaris: analyzing the pathogenicity of anti‐desmoglein 3 antibodies using a bead aggregation assay

International journal of dermatology, 2024-07, Vol.63 (7), p.956-958

2024

Volltextzugriff (PDF)

Detection of anti‐BP180 NC16A autoantibodies after the onset of dipeptidyl peptidase‐IV inhibitor‐associated bullous pemphigoid: a report of three patients

British journal of dermatology (1951), 2018-09, Vol.179 (3), p.790-791

2018

Volltextzugriff (PDF)

Checkpoint inhibitor‐associated bullous cutaneous immune‐related adverse events: a multicentre observational study

British journal of dermatology (1951), 2022-12, Vol.187 (6), p.981-987

2022

Volltextzugriff (PDF)

Missed drug-induced bullous pemphigoid leads to longer immunosuppression than recognized cases: A 9-year retrospective review

Journal of the American Academy of Dermatology, 2020-05, Vol.82 (5), p.1255-1258

2020

Volltextzugriff (PDF)

Single-Cell Profiling Unveils the Inflammatory Heterogeneity within Cutaneous Lesions of Bullous Pemphigoid

Journal of investigative dermatology, 2024-10, Vol.144 (10), p.2176-2186.e6

2024

Volltextzugriff (PDF)

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1

Cancer immunology research, 2016-05, Vol.4 (5), p.383-389

2016

Volltextzugriff (PDF)

Nodular formation in anti‐laminin γ1 pemphigoid

Journal of dermatology, 2020-03, Vol.47 (3), p.e80-e82

2020

Volltextzugriff (PDF)

Reactivity against the BP180 ectodomain in patients with bullous pemphigoid, mucous membrane pemphigoid, multiple sclerosis and Parkinson disease

Experimental dermatology, 2024-07, Vol.33 (7), p.e15125-n/a

2024

Volltextzugriff (PDF)

Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies

Melanoma research, 2016-08, Vol.26 (4), p.413-416

2016

Volltextzugriff (PDF)

A new clinical variant of acquired reactive perforating dermatosis‐like bullous pemphigoid

British journal of dermatology (1951), 2019-01, Vol.180 (1), p.231-232

2019

Volltextzugriff (PDF)

The global incidence of bullous pemphigoid: a systematic review and meta‐analysis

British journal of dermatology (1951), 2022-03, Vol.186 (3), p.414-425

2022

Volltextzugriff (PDF)

Grover disease and bullous pemphigoid: a clinicopathological study of six cases

Clinical and experimental dermatology, 2019-07, Vol.44 (5), p.524-527

2019

Volltextzugriff (PDF)

Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII

Journal of dermatology, 2017-10, Vol.44 (10), p.e240-e241

2017

Volltextzugriff (PDF)

Sequential occurrence of primary cutaneous indeterminate cell histiocytosis after oesophageal cancer and subsequent bullous pemphigoid: a case report

British journal of hospital medicine (London, England : 2005), 2024-07, Vol.85 (7), p.1-7

2024

Volltextzugriff (PDF)

Intravenous immunoglobulin in patients with bullous pemphigoid insufficient response to corticosteroids: Nationwide post-marketing surveillance in Japan

Journal of dermatological science, 2023-01, Vol.109 (1), p.22-29

2023

Volltextzugriff (PDF)

Pemphigoid of the pulmonary system

Annales de dermatologie et de vénéréologie, 2024-06, Vol.151 (2), p.103253, Article 103253

2024

Volltextzugriff (PDF)

Bullous pemphigoid associated with cutaneous adnexal carcinoma

EJD. European journal of dermatology, 2024-06, Vol.34 (3), p.306-308

2024

Volltextzugriff (PDF)

Clinical characteristics, mortality, and prognostic factors for bullous pemphigoid in a Thai population

Medicine (Baltimore), 2020-10, Vol.99 (43), p.e22850-e22850

2020

Volltextzugriff (PDF)

Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab‐induced bullous pemphigoid

International journal of dermatology, 2018-11, Vol.57 (11), p.1372-1374

2018

Volltextzugriff (PDF)

1 – 25 von 636

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

ThemaPemphigoid, Bullous - Drug Therapy

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(541)
Mit Volltextzugriff
(445)

Publikationsform

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(630)
Science & Technology
(482)
Life Sciences & Biomedicine
(479)
Dermatology
(391)
Male
(376)
Female
(352)
Pemphigoid, Bullous - Pathology
(205)
Pemphigoid, Bullous - Immunology
(182)
Biological And Medical Sciences
(172)
Medical Sciences
(170)
Pemphigoid, Bullous - Diagnosis
(166)
Bullous Pemphigoid
(163)
Aged, 80 And Over
(153)
Pemphigoid, Bullous - Complications
(126)
Bullous Diseases Of The Skin
(119)
Diagnosis, Differential
(97)
Pemphigoid, Bullous - Chemically Induced
(88)
Skin - Pathology
(76)
Pemphigoid, Bullous - Etiology
(75)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid

Nonbullous pemphigoid: A systematic review

Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid

Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome

Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid

A case of bullous pemphigoid complicated by mucosal lesions due to mucosal‐dominant pemphigus vulgaris: analyzing the pathogenicity of anti‐desmoglein 3 antibodies using a bead aggregation assay

Detection of anti‐BP180 NC16A autoantibodies after the onset of dipeptidyl peptidase‐IV inhibitor‐associated bullous pemphigoid: a report of three patients

Checkpoint inhibitor‐associated bullous cutaneous immune‐related adverse events: a multicentre observational study

Missed drug-induced bullous pemphigoid leads to longer immunosuppression than recognized cases: A 9-year retrospective review

Single-Cell Profiling Unveils the Inflammatory Heterogeneity within Cutaneous Lesions of Bullous Pemphigoid

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1

Nodular formation in anti‐laminin γ1 pemphigoid

Reactivity against the BP180 ectodomain in patients with bullous pemphigoid, mucous membrane pemphigoid, multiple sclerosis and Parkinson disease

Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies

A new clinical variant of acquired reactive perforating dermatosis‐like bullous pemphigoid

The global incidence of bullous pemphigoid: a systematic review and meta‐analysis

Grover disease and bullous pemphigoid: a clinicopathological study of six cases

Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII

Characterization of the skin microbiota in bullous pemphigoid patients and controls reveals novel microbial indicators of disease

Sequential occurrence of primary cutaneous indeterminate cell histiocytosis after oesophageal cancer and subsequent bullous pemphigoid: a case report

Intravenous immunoglobulin in patients with bullous pemphigoid insufficient response to corticosteroids: Nationwide post-marketing surveillance in Japan

Pemphigoid of the pulmonary system

Bullous pemphigoid associated with cutaneous adnexal carcinoma

Clinical characteristics, mortality, and prognostic factors for bullous pemphigoid in a Thai population

Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab‐induced bullous pemphigoid

Aktive Filter

Suchergebnisse filtern